Shandong Qiansheng Innovation Biology Co., Ltd. has invested 470 million yuan to build a project with an annual production capacity of 1,500 tons of pharmaceutical intermediate materials

Thread Content

Recently, information regarding Shandong Qiansheng Innovation Biology Co., Ltd.’s 22,000-ton biofermentation project and the project for producing 1,500 tons of oxacillin sodium intermediates per year was published on relevant websites. Biological fermentation project with an annual output of 22,000 tons
Project name: Shandong Qiansheng Innovation Biology Co., Ltd. – 22,000-ton biological fermentation project
Nature of the construction: New construction
Location: Boxing Chemical Industry Park, Binzhou City, Shandong Province
Constructor: Shandong Qiansheng Innovation Biology Co., Ltd.
Project investment: 476.73 million yuan
Project overview: The project covers an area of 121.3 mu, with a total construction area of 32,200 square meters. It includes 54,559 square meters of factory space. The project will feature one production line for salinomycin, one for tylosin, and one for monensin. There will be 224 sets of equipment for salinomycin production, 233 sets for tylosin production, 90 sets for monensin production, and 23 sets of equipment for the tank area. The biological fermentation process, along with the extraction process using butyl acetate (a hazardous chemical), will be employed. Upon completion, the project will have an annual output of 15,000 tons of salinomycin, 2,000 tons of tylosin, and 5,000 tons of monensin. Project name for the construction of a facility capable of producing 1,500 tons per year of oxacillin sodium intermediates: Shandong Qiansheng Innovation Biology Co., Ltd. – Project for Producing 1,500 Tons Per Year of Oxacillin Sodium Intermediates ； Site and route selection: Boxing Chemical Industry Park (Shengli Technology Zone), Binzhou City, Shandong Province ； Construction details: The project is located in the Boxing Chemical Industry Park in Binzhou City, Shandong Province. Facilities such as a filtration workshop, an extraction workshop, and warehouses will be built, enabling an annual production capacity of 1,500 tons of oxacillin sodium intermediates upon completion. Shandong Qiansheng Innovation Biology Co., Ltd. is a biotechnology company established in April 2025, with a registered capital of 50 million yuan; it is located in Boxing County, Binzhou, Shandong. The company is mainly engaged in the research, development, and sales of bio-organic fertilizers, chemical products, and bio-based materials, with its business covering various fields such as biochemistry, industrial enzyme preparations, and compound microbial fertilizers.